Evidence map›Paper›PMID 16940501›Full record

ArticleJournal of virology2006

Identification of amino acid residues within simian virus 40 capsid proteins Vp1, Vp2, and Vp3 that are required for their interaction and for viral infection.

Akira Nakanishi, Akiko Nakamura, Robert Liddington, Harumi Kasamatsu

Abstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A structural rationale for SV40 Vp1 temperature-sensitive mutants and their complementation.Protein science : a publication of the Protein Society · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Akira NakanishiMolecular Biology Institute, University of California-Los Angeles, 611 East Charles E. Young Drive, Los Angeles, CA 90095-1570, USA.
Akiko Nakamura
Robert Liddington
Harumi Kasamatsu

Funding

ASSEMBLY AND MORPHOGENESIS OF DNA TUMOR VIRUSESR01CA050574 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KASAMATSU, HARUMI · 1990 to 2006
$1.9M
NCI NIH HHS CA 50574NCI NIH HHS R01 CA050574
6 · The paper itself

Abstract

Interaction of simian virus 40 (SV40) major capsid protein Vp1 with the minor capsid proteins Vp2 and Vp3 is an integral aspect of the SV40 architecture. Two Vp3 sequence elements mediate Vp1 pentamer binding in vitro, Vp3 residues 155 to 190, or D1, and Vp3 residues 222 to 234, or D2. Of the two, D1 but not D2 was necessary and sufficient to direct the interaction with Vp1 in vivo. Rational mutagenesis of Vp3 residues (Phe157, Ile158, Pro164, Gly165, Gly166, Leu177, and Leu181) or Vp1 residues (Val243 and Leu245), based on a structural model of the SV40 Vp1 pentamer complexed with Vp3 D1, was carried out to disrupt the interaction between Vp1 and Vp3 and to study the consequences of these mutations for viral viability. Altering these residues to bulky, charged residues blocked the interaction in vitro. When these alterations were introduced into the viral genome, they reduced viral viability. Mutants with alterations in Vp1 Val243, Leu245, or both to glutamate were nearly nonviable, whereas those with Vp3 alterations reduced, but did not eliminate, viability. Our results defined the residues of Vp1 and the minor capsid proteins that are essential for both the interaction of the capsid proteins and viral viability in permissive cells.

Indexed as

AnimalsCapsid ProteinsCell LineChlorocebus aethiopsHumansMutationPolyomavirus InfectionsProtein ConformationProtein Structure, TertiaryRecombinant ProteinsTumor Virus InfectionsCapsid ProteinsRecombinant ProteinsVP1 protein, polyomavirusVp2 protein, simian virus 40VP3 protein, Simian virus 40

Identifiers

PMID16940501
PMCPMC1563927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.